Pre-study of acupuncture for postmenopausal osteoporosis
- Conditions
- postmenopausal osteoporosis
- Registration Number
- ITMCTR2200006783
- Lead Sponsor
- Wangjing Hospital of China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
(1)Meets diagnostic criteria for postmenopausal osteoporosis
(2)Patients with postmenopausal osteoporosis between the ages of 45 (inclusive) and 70 (exclusive)
(3)Baseline VAS = 4 points and VAS < 7 points
(4)Voluntary participation in this clinical study, signed informed consent form
(1)Secondary osteoporosis or history of osteoporotic fracture within the last 1 year
(2)Combined with rheumatoid arthritis, osteoarthritis, diabetes, gastrointestinal diseases, etc.
(3)Severe cardiac, hepatic, renal and other organ insufficiencies, hematologic and autoimmune diseases, acute and chronic infections, malignant tumors, or serious mental illnesses
(4)History of thyroid, pituitary, hypothalamus and other endocrine disorders
(5)Use of zoledronate within the last 1 year, use of disulfiramab within the last 6 months, oral bisphosphonates Salt, anti-osteoporosis herbal preparations such as bone care capsule, Jin Tian Ge capsule, etc. discontinued for less than 3 months
(6)Year-round use of hormones such as glucocorticoids, sex hormones, active vitamin D, fluoride, anti-seizure epileptic drugs, etc.
(7)Those unable to cooperate in completing this study
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain;
- Secondary Outcome Measures
Name Time Method Bone metabolism markers;Quality of life;Security indicators;TCM Syndrome Score;